journal article·2026-08Open access

Mitochondria-targeted phototherapeutic system enabling spatiotemporal-controlled NADH depletion for keloid intervention

Fugang Xiao, Xiang Cheng, Jianbo Chen, Yanpeng Fang, Xingru Zhou, Conghui Liu, Zhibing Fu, Ningling Wu, Yifei Xie, Lu Zhou, Shenming Xu, Wenbing Zeng, Jinrong Zeng

Abstract

Keloids represent a fibroproliferative disorder characterized by excessive collagen deposition and dysregulated cellular metabolism, yet effective therapeutic strategies remain limited due to the lack of precise intervention at the subcellular level. Herein, we report a mitochondria-targeted phototherapeutic system ( TBQQPt ) that enables spatiotemporal-controlled metabolic disruption through light-triggered NADH depletion. Unlike conventional photosensitizers that primarily rely on reactive oxygen species (ROS) generation, TBQQPt integrates mitochondrial localization with redox intervention, allowing localized consumption of NADH and amplification of oxidative stress within mitochondria. Mechanistically, TBQQPt accumulates in mitochondria and, upon light irradiation, induces efficient NADH oxidation, leading to mitochondrial dysfunction, enhanced ROS generation, and subsequent fibroblast inactivation. This dual mechanism establishes a self-amplifying therapeutic cascade that disrupts cellular energy metabolism and redox homeostasis. In vitro studies demonstrate significant inhibition of fibroblast proliferation and collagen production. In vivo, TBQQPt -mediated phototherapy effectively suppresses keloid progression with minimal off-target toxicity, as further supported by transcriptomic analysis revealing downregulation of fibrosis- and metabolism-related pathways. Overall, this work provides a subcellularly targeted and spatiotemporally controllable strategy for keloid treatment, highlighting the potential of integrating drug delivery with metabolic intervention for precision therapy of fibrotic diseases.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Laser Applications in Dentistry and Medicine · Hydrogen's biological and therapeutic effects · Dermatologic Treatments and Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (36)

Show source-provided references
1. Characterization of the skin keloid microenvironment10.1186/s12964-023-01214-0 ↗
2. Keloids revisited: current concepts in treatment and differential diagnosis10.1016/j.canlet.2025.217802 ↗
3. Comprehensive insights into keloid pathogenesis and advanced therapeutic strategies10.3390/ijms25168776 ↗
4. Altered glucose metabolism and cell function in keloid fibroblasts under hypoxia10.1016/j.redox.2020.101815 ↗
5. Targeting the glycolytic enzyme pgk1 to inhibit the warburg effect: a new strategy for keloid therapy10.1097/PRS.0000000000010137 ↗
6. Apoptotic bodies restore nad and mitochondrial homeostasis in fibroblasts
7. PI3K/akt pathway promotes keloid fibroblasts proliferation by enhancing glycolysis under hypoxia10.1111/wrr.13067 ↗
8. Viewing keloids within the immune microenvironment
9. Epigenetic silencing of sod2 exacerbates mitochondrial oxidative stress and promotes pulmonary fibrosis10.1016/j.freeradbiomed.2025.04.034 ↗
10. The arts of p53-dependent mitochondrial apoptosis10.1093/jmcb/mjac074 ↗
11. Photodynamic therapy: overview and mechanism of action10.1016/j.jaad.2025.02.037 ↗
12. Towards overcoming obstacles of type ii photodynamic therapy: endogenous production of light, photosensitizer, and oxygen10.1016/j.apsb.2023.11.007 ↗
13. Subcellular targeting strategies: chemical structure-based design concepts for bioimaging and theranostics10.1016/j.celbio.2024.100001 ↗
14. Orthogonal upconversion nanocarriers for combined photodynamic therapy and precisely triggered gene silencing in combating keloids10.1016/j.jconrel.2024.12.080 ↗
15. Tumor microenvironment-responsive engineered hybrid nanomedicine for photodynamic-immunotherapy via multi-pronged amplification of reactive oxygen species10.1038/s41467-024-55658-0 ↗
16. Activatable type i photosensitizer with quenched photosensitization pre and post photodynamic therapy10.1002/anie.202307288 ↗
17. Mitochondria-targeted nanoparticles (mitonano): an emerging therapeutic shortcut for cancer10.1016/j.bbiosy.2021.100023 ↗
18. Lipophilic cations as mitochondria-targeting moieties: recent progress and design principles for medicinal chemistry10.1021/acs.jmedchem.5c02076 ↗
19. Metal-based photosensitizers for photodynamic therapy: the future of multimodal oncology?10.1016/j.cbpa.2019.10.004 ↗
20. Cellular and molecular mechanisms of fibrosis10.1002/path.2277 ↗
21. Photodynamic therapy: past, current, and future10.3390/ijms252011325 ↗
22. Donor-acceptor hybrid heterostructures: an emerging class of photoactive materials with inorganic and organic semiconductive components10.1002/smll.202201159 ↗
23. Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications10.1021/acs.chemrev.7b00042 ↗
24. Aggregation-induced emission: together we shine, united we soar10.1021/acs.chemrev.5b00263 ↗
25. Efficient construction of near-infrared absorption donor-acceptor copolymers with and without pt(ii)-incorporation toward broadband nonlinear optical materials10.1021/acsami.9b17784 ↗
26. The el-sayed’s rule analogy enables long-lived room temperature phosphorescence in twisted biphenyls
27. Anticancer activity and cell death mechanism of pt(ii) complexes: their in vitro bio-transformation to pt(ii)-dna adduct formation and bsa binding study by spectroscopic method10.1016/j.saa.2021.120096 ↗
28. Mitochondrial endogenous substance transport-inspired nanomaterials for mitochondria-targeted gene delivery10.1016/j.addr.2024.115355 ↗
29. Mitochondria-targeted multifunctional nanoprodrugs by inhibiting metabolic reprogramming for combating cisplatin-resistant lung cancer10.1021/acsnano.4c04024 ↗
30. Endothelial dysfunction in keloid formation and therapeutic insights10.1016/j.jid.2025.02.134 ↗
31. Type i photodynamic therapy by organic–inorganic hybrid materials: from strategies to applications10.1016/j.ccr.2019.05.016 ↗
32. Human skin keloid fibroblasts display bioenergetics of cancer cells10.1038/sj.jid.5701107 ↗
33. Fibroblast activation protein targeting radiopharmaceuticals: from drug design to clinical translation
34. Mitochondrial membrane permeabilization in cell death10.1152/physrev.00013.2006 ↗
35. Nutritional and hormonal regulation of mitochondrial biogenesis drives fat body remodeling for reproductive competence10.1016/j.jare.2025.04.041 ↗
36. Low‐frequency ultrasound sensitive piezo1 channels regulate keloid‐related characteristics of fibroblasts